Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

• Автори: Hong Luo (Автор), Yanping Xiao (Автор), Yaping Hang (Автор), Yanhui Chen (Автор), Hongying Zhu (Автор), Xueyao Fang (Автор), Xingwei Cao (Автор), Shan Zou (Автор), Xiaoyan Hu (Автор), Jianqiu Xiong (Автор), Qiaoshi Zhong (Автор), Longhua Hu (Автор)
• Формат: Книга
• Опубліковано: BMC, 2021-09-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Abstract Background Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae has become a public health concern. This study aimed to compare the clinical outcomes of patients with nonurinary source bacteraemia caused by ESBL-producing Escherichia coli (E. coli) or Klebsiella pneumoniae (ESB...